Abstract
Background
Socioeconomic and racial differences have been associated with disparities in cancer care within the US, including disparate access to minimally invasive surgery for rectal cancer. We hypothesized that robotic approach to rectal cancer may be associated with similar disparities.
Methods
The National Cancer Database (NCDB) was used to identify patients over 18 years old with clinical stage I–III rectal adenocarcinoma who underwent a proctectomy between 2010 and 2014. Demographic and hospital factors were analyzed for association with robotic approach. Factors identified on bivariate analyses informed multivariate analysis.
Results
We identified 33,503 patients who met inclusion criteria; 3702 (11.1%) underwent robotic surgery with 7.8% conversion rate. Patients who received robotic surgery were more likely to be male, white, privately insured and with stage III cancer. They were also more likely to live in a metropolitan area, more than 25 miles away from the hospital and with a higher high school graduation rate. The treating hospital was more likely to be academic and high volume.
Conclusions
Robotic surgery is performed rarely and access to it is limited for patients who are female, black, older, non-privately insured and unable to travel to high-volume teaching institutions. The advantages of robotic surgery may not be available to all patients given disparate access to the robot. This inherent bias in access to robot may skew study populations, preventing generalizability of robotic surgery research.
Graphic abstract
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Socioeconomic and racial disparities can place patients at a disadvantage in receiving cutting-edge healthcare. Prior studies have demonstrated that treatment and outcome disparities associated with patient demographics can alter treatment at all stages of rectal cancer care [1]. Minimally invasive (MIS) approaches to rectal cancer resection, including both laparoscopic and robotic surgery, has been previously associated with insurance status [2]. Robotic surgery for rectal cancer care may mimic these trends in disparate access.
Robotic rectal resection has experienced growing market share of proctectomies in the United States [3,4,5]. In urologic literature, access to hospitals performing robotic prostatectomy was noted to be disproportionately associated with race/ethnicity, income and insurance status [6]. Similarly, robotic hysterectomy is less likely to be performed in black women compared to white, women in lower income categories and women covered by Medicaid [7].
Given unequal access to robotic surgery in other disciplines, the aim of this study was to evaluate if disparities exist in robotic surgery for rectal cancer. This would characterize patient population with limited access to this technology, and to provide insight into the generalizability of clinical trials assessing long-term outcomes of robotic proctectomy. We hypothesized that there would be significant racial and socioeconomic disparities in robotic proctectomy access.
Methods
The National Cancer Database (NCDB) is a nationally recognized oncologic data repository sponsored by the American College of Surgeons and the American Cancer Society. It is collected from Commission on Cancer-accredited medical centers, and includes over 70% of new cancer diagnoses nationwide. The NCDB for rectal cancer was used to identify patients 18 years of age and older with clinical stage I–III rectal adenocarcinoma who underwent a proctectomy between 2010 and 2014, because data on operative approach was only available in NCDB after 2010. Patients with clinical stage I–III rectal adenocarcinoma were included in the analysis. Only patients with adenocarcinoma of the rectum were included. Partial and total proctectomies were included in the analysis; local excisions and unspecified surgery were excluded. Procedures without a specified operative approach, (open, laparoscopic or robotic), were excluded from analysis. Given de-identified nature of the publically available NCDB dataset, this study was designated as “not human subjects research” by our institutional review board, and IRB review, approval and written consent were not required.
Statistical analysis
The outcome of interest was whether a patient received robotic proctectomy. Robotic surgery was defined by intention to treat; patients who were selected for robotic proctectomy but underwent a conversion to an open procedure were included in the robotic cohort for the purpose of this analysis. Bivariate analyses were performed using Pearson χ2 tests to evaluate for associations between receiving robotic surgery and demographic, socioeconomic, hospital, and clinical factors. Individual demographic variables comprised of sex, age, race, and type of insurance. Clinical factors included Charlson–Deyo score (as a descriptor of comorbidity) and preoperative disease stage. NCDB provides proxy variables for income and level of education based on zip code data. Percent of people living in the patient’s area of residence who obtained a high school degree (ranging from < 7 to > 21%) and median household income (ranging in quartiles from < $38,000 and > $63,000) derived from 2012 American Community Survey data were used to as estimates of individual socioeconomic status. Patient residence in metropolitan, urban or rural counties and distance from the hospital were used as estimates of physical access to a medical facility. A practice volume variable was created by stratifying all hospitals into three categories based on number of proctectomies performed annually (< 100, 100–300 and > 300). A facility identifier used was academic hospital status, defined by NCDB as a hospital that participates in postgraduate medical education and diagnosing over 500 new cancers per year.
After determining which variables were statistically significant in the bivariate analyses, a multivariable logistic regression was performed to evaluate the adjusted relationships to receiving robotic surgery. Areas under the receiver operating characteristic (ROC) curve were calculated to identify the best fitting iteration of the logistic model. Statistical significance was set at p < 0.05. Statistical analysis was performed using StataIC (version 15.1.635).
Results
Between 2010 and 2014, 33,503 patients met inclusion criteria; see Fig. 1 for inclusion and exclusion criteria flow diagram. Of all patients undergoing proctectomy, 20,764 (62.0%) were male and 12,739 (38.0%) were female; 26,304 (78.5%) were white, 2614 (7.8%) were black and 4585 (13.7%) were recorded as a race other than black or white (Table 1).
Robotic proctectomy was performed in 3702 (11.1%) patients, and of those, 290 (7.8%) required conversion to open. Differences between the groups that received robotic versus non-robotic proctectomy is shown in Table 1. Patients who received robotic surgery rather than laparoscopic or open were statistically more likely to be male (64.4% vs. 61.7%), white (79.3% vs. 78.4%), under 50 years of age (18.6% vs. 17.0%), clinical stage III (43.7% vs. 41.5%), and privately insured (53.4% vs. 46.3%) all p < 0.011. Patients receiving robotic proctectomy were more likely to be living in a metropolitan area (82.7% vs. 80.1%), 20–25 miles away from the hospital (16.5% vs. 13.9%), in a zip code area with the highest income quartile (35.6% vs. 31.0%) and highest rate of high school graduation (27.0% vs. 23.1%), all p ≤ 0.001. In addition, patients undergoing robotic proctectomy were more likely to be treated at an academic (65.6% vs. 52.8%) and high volume (30.6% vs. 25.1%) medical center, all p < 0.001.
Effect of race on robotic approach
Black patients were significantly less likely to undergo robotic proctectomy on both unadjusted (OR 0.75, 95% CI 0.65–0.87, p < 0.001) and adjusted analyses (OR 0.79, 95% CI 0.68–0.91, p = 0.002) (Tables 1 and 2). There was no significant association with robotic approach for other racial groups on unadjusted analysis (Table 2).
Effect of socioeconomic factors on robotic approach
Patient insurance, zip code area, and distance from the treating hospital were all significant factors on adjusted multivariate analysis. Patients with Medicare/Medicaid or VA insurance (OR 0.94 95% CI 0.90–0.98, p = 0.004) and no insurance (OR 0.46, 95% CI 0.37–0.58, p < 0.001) were less likely to undergo robotic surgery for rectal cancer. Living less than 25 miles away from the hospital was associated with a smaller likelihood of robotic approach (OR 0.79, 95% CI 0.72–0.86, p < 0.001). Compared to metropolitan residents, patients who lived in urban or rural settings were less likely to undergo robotic surgery (OR 0.8, 95% CI 0.72–0.90, p < 0.001 and OR 0.77, 95% CI 0.60–0.99, p = 0.043, respectively). Patients who resided in a zip code with a larger percentage of high school graduates were more likely to undergo surgery using the robotic approach (Table 2).
Effect of hospital factors on robotic approach
On adjusted multivariate analysis, patients who received a proctectomy at an academic medical center (OR 1.43 95% CI 1.33–1.55 p < 0.001) were more likely to have a robotic procedure than those admitted to a non-academic hospital. Similarly, patients at moderate-volume (OR 1.69 95% CI 1.53–1.86 p < 0.001), and high-volume centers (OR 1.59 95% CI 1.42–1.78 p < 0.001) also more likely to undergo a robotic procedure when compared to low-volume rectal cancer surgery centers (Table 2).
Discussion
The purpose of this study was to determine if access to robotic rectal cancer resection varies by patient population. These data show that patients are less likely to have access to robotic surgery if they are female, black, non-privately insured, do not travel for surgical care, are residents of non-metropolitan settings, or reside in less educated areas. Conversely, patients who receive their surgical care in academic, high-volume hospitals have a higher chance of undergoing robotic proctectomy.
Our study found that for robotic surgery, both socioeconomic status and race correlate independently, similar to prior studies of robotic gynecologic and urologic procedures [6, 7]. Previous studies of patients with rectal cancer suggested that insurance, but not race, was associated with access to MIS approaches for cancer resection; of note, the studied patient populations predominantly underwent laparoscopic intervention [2, 8, 9]. This study suggests that factors associated with variations in access to robotic surgery may differ from laparoscopic approach or MIS overall.
There are patient factors that may inform the choice of a robotic proctectomy. For one, patient preference may explain some difference in populations that undergo robotic approach, as certain patient populations are more mistrustful of newer medical technology [10]. Some surgeons prefer robotic proctectomy for male patients as robotic surgery increases ease of operation in the narrow male pelvis. The ROLARR trial demonstrated lower conversion rates for robotic approach compared to laparoscopic in male patients [11]. A study by Ackerman et al. found that male patients were more likely to undergo conversion overall, but robotic surgery was protective against conversion compared to laparoscopic surgery [12]. The difficulty of the dissection in the narrow male pelvis may be a driver of the disparities for the increased selection of males having robotic surgery [13,14,15].
Institutional factors also appear to contribute to differences in access to robotic rectal surgery [16]. Ability to afford the robot varies among institutions and access to the robot may attract a particular type of surgeon. Robotic surgery is used in advertising for both hospitals and colorectal surgeons [17]. Hospitals serving more affluent, well-educated and privately insured patients may offer robotic operations to attract those drawn to a high-tech approach to surgery, contributing to socioeconomic disparities [17, 18]. These forces, which concentrate resources, equipment, and expertise, may also inadvertently affect access to patients who are unable to travel to receive their care, such as those with lower socioeconomic status.
This study is limited by its retrospective nature and lack of data granularity inherent in large databases like NCDB. For example, there is no data on number of prior abdominal surgeries which may influence decision of operative approach nor patient or surgeon preference on choice of robotic surgery. Another limitation is that this time period was limited by the availability of data. More than half of all rectal resections or 63,686 patients were excluded because operative approach was not specified in the NCDB prior to 2010. At time of data analysis, our institution only had NCDB data up to 2014. During this time period, robotic surgery faced a period of expansion and, compared to now, training opportunities were less available. This could have influenced the results of this study and therefore alter the generalizability of our findings. Nonetheless, NCDB is a large database, capturing close to 70% of cancer patients; [19] therefore, we believe that the findings of this study are sufficient to represent trends in access to robotic rectal surgery in the United States.
All patient populations do not undergo robotic proctectomy in equal proportions. Herein, using the NCDB we demonstrate a clear association of specific populations to access to robotic surgery, including patients who are male, non-black, privately insured, who have ability to travel for medical care and reside in metropolitan, highly educated areas. This data does not demonstrate that having access to robot improves patient care, but given this bias, surgeon researchers must be cognizant of study population diversity and generalizability of robotic surgery research. Further areas of investigation should evaluate why these discrepancies exist.
References
Lee DY, Teng A, Pedersen RC et al (2017) Racial and socioeconomic treatment disparities in adolescents and young adults with stage II–III rectal cancer. Ann Surg Oncol 24(2):311–318. https://doi.org/10.1245/s10434-016-5626-0
Turner M, Adam MA, Sun Z et al (2017) Insurance status, not race, is associated with use of minimally invasive surgical approach for rectal cancer. Ann Surg 265(4):774–781. https://doi.org/10.1097/SLA.0000000000001781
Ohtani H, Maeda K, Nomura S et al (2018) Meta-analysis of robot-assisted versus laparoscopic surgery for rectal cancer. Vivo 32(3):611–623. https://doi.org/10.21873/invivo.11283
Liao G, Li Y-B, Zhao Z, Li X, Deng H, Li G (2016) Robotic-assisted surgery versus open surgery in the treatment of rectal cancer: the current evidence. Sci Rep 6(1):26981. https://doi.org/10.1038/srep26981
Silva-Velazco J, Dietz DW, Stocchi L et al (2017) Considering value in rectal cancer surgery: an analysis of costs and outcomes based on the open, laparoscopic, and robotic approach for proctectomy. Ann Surg 265(5):960–968. https://doi.org/10.1097/SLA.0000000000001815
Kim J, ElRayes W, Wilson F et al (2015) Disparities in the receipt of robot-assisted radical prostatectomy: between-hospital and within-hospital analysis using 2009-2011 California inpatient data. BMJ Open 5(4):e007409. https://doi.org/10.1136/bmjopen-2014-007409
Price JT, Zimmerman LD, Koelper NC, Sammel MD, Lee S, Butts SF (2017) Social determinants of access to minimally invasive hysterectomy: reevaluating the relationship between race and route of hysterectomy for benign disease. Am J Obstet Gynecol 217(5):572.e1–572.e10. https://doi.org/10.1016/J.AJOG.2017.07.036
Turner MC, Adam MA, Sun Z et al (2018) Response to letter: comment on “insurance status, not race is associated with use of minimally invasive surgical approach for rectal cancer”. Ann Surg 267(2):e30. https://doi.org/10.1097/SLA.0000000000001974
Gabriel E, Thirunavukarasu P, Al-Sukhni E, Attwood K, Nurkin SJ (2016) National disparities in minimally invasive surgery for rectal cancer. Surg Endosc 30(3):1060–1067. https://doi.org/10.1007/s00464-015-4296-5
Harrop E, Kelly J, Griffiths G, Casbard A, Nelson A, Published on behalf of the BOLERO Trial Management Group (TMG) P on behalf of the BTMG (2016) Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic or RObotic cystectomy). Trials 17:35. https://doi.org/10.1186/s13063-016-1173-z
Jayne D, Pigazzi A, Marshall H et al (2017) Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer. JAMA 318(16):1569. https://doi.org/10.1001/jama.2017.7219
Ackerman SJ, Daniel S, Baik R et al (2018) Comparison of complication and conversion rates between robotic-assisted and laparoscopic rectal resection for rectal cancer: which patients and providers could benefit most from robotic-assisted surgery? J Med Econ 21(3):254–261. https://doi.org/10.1080/13696998.2017.1396994
D’Annibale A, Morpurgo E, Fiscon V et al (2004) Robotic and laparoscopic surgery for treatment of colorectal diseases. Dis Colon Rectum 47(12):2162–2168. https://doi.org/10.1007/s10350-004-0711-z
Moszkowicz D, Alsaid B, Bessede T et al (2011) Where does pelvic nerve injury occur during rectal surgery for cancer? Color Dis 13(12):1326–1334. https://doi.org/10.1111/j.1463-1318.2010.02384.x
Hyuk Baik S, Kyu Kim N, Young Lee K et al (2008) Factors influencing pathologic results after total mesorectal excision for rectal cancer: analysis of consecutive 100 cases. Ann Surg Oncol 15(3):721–728. https://doi.org/10.1245/s10434-007-9706-z
Fantus RJ, Cohen A, Riedinger CB et al (2018) Facility-level analysis of robot utilization across disciplines in the National Cancer Database. J Robot Surg. https://doi.org/10.1007/s11701-018-0855-9
Alkhateeb S, Lawrentschuk N (2011) Consumerism and its impact on robotic-assisted radical prostatectomy. BJU Int 108(11):1874–1878. https://doi.org/10.1111/j.1464-410X.2011.10117.x
Gomes P (2011) Surgical robotics: reviewing the past, analysing the present, imagining the future. Robot Comput Integr Manuf 27(2):261–266. https://doi.org/10.1016/J.RCIM.2010.06.009
Mallin K, Browner A, Palis B et al (2019) Incident cases captured in the national cancer database compared with those in U.S. Population Based Central Cancer Registries in 2012–2014. Ann Surg Oncol. https://doi.org/10.1245/s10434-019-07213-1
Acknowledgements
We acknowledge the support of the University Hospitals Cleveland Medical Center Surgery Department and UH-RISES: Research in Surgical Outcomes & Effectiveness Center.
Funding
This investigation was funded by the University Hospitals Cleveland Medical Center Surgery Department.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Dr. Stein has been a speaker for Merck and advisory consultant for Medtronics. Dr. Towe is a consultant for Medtronic, Atricure, Sig Medical, and Zimmer Biomet. Drs. Steinhagen, Bingmer and Ofshteyn have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ofshteyn, A., Bingmer, K., Towe, C.W. et al. Robotic proctectomy for rectal cancer in the US: a skewed population. Surg Endosc 34, 2651–2656 (2020). https://doi.org/10.1007/s00464-019-07041-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-019-07041-0